BASEL, Switzerland, Sept. 16, 2025 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) shared real-world evidence from the rollout of Accu-Chek SmartGuide continuous glucose monitoring (CGM) solution ...
The integration of Accu-Chek SmartGuide's AI-enabled predictive CGM with the popular mySugr app delivers a simple, intuitive solution for people to manage their diabetes with greater ease. Accu-Chek ...
Roche Holding RHHBY recently announced that it has received the CE Mark for its Accu-Chek SmartGuide continuous glucose monitoring (CGM) solution. With the approval, CGM solution can now be made ...
Health Canada has issued a recall for some Accu-Chek Guide devices due to inaccurate blood glucose readings. Certain units of the medical measurement device incorrectly display blood glucose levels, ...
Roche, a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives, announced the launch of the Accu-Chek Guide, the next-generation blood glucose ...
Accu-Chek® + 360Care™ offers patients living with Type 1 and Type 2 diabetes innovative personalised solutions, empowering patients to actively monitor their glucose with real-time professional ...
Cuireadh roinnt torthaí i bhfolach toisc go bhféadfadh siad a bheith dorochtana duit
Taispeáin torthaí dorochtana
Aiseolas